Muscle and Fitness on MSN3 个月
Study Shows How Orexin Makes You Snack Instead of Sweat
The study, recently published in Nature Nueroscience, observed that levels of the brain chemical orexin may directly ...
pharmaphorum5 天
Idorsia is first to EU market with orexin insomnia drug
Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.
Taiwan News7 天
Nxera Pharma Enrolls First Insomnia Patient in its Phase 3 Clinical Trial of Daridorexant ...
Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia QUVIVIQ™ (daridorexant) 25 and 50 mg was recently approved and is expected ...
Zenopa13 天
TheraCryf: European Patent Office to award patent for Ox-1 antagonist
TheraCryf’s highly selective Ox-1 receptor antagonist was acquired as part of its acquisition of Chronos Therapeutics Ltd in ...